RMD Oct 2024 210.000 put
| Previous close | 15.50 |
| Open | 14.70 |
| Bid | 12.30 |
| Ask | 12.90 |
| Strike | 210.00 |
| Expiry date | 2024-10-18 |
| Day's range | 14.70 - 15.60 |
| Contract range | N/A |
| Volume | |
| Open interest | 11 |
ZacksAlign Technology (ALGN) Gains From New Alliances, Global Growth
Align Technology (ALGN) is expanding its sales and marketing by reaching new countries and regions, including new areas within Africa and Latin America.
Zacks4 GARP Stocks to Scoop up for Maximum Returns
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RMD, BAH, BAP and AXP are some stocks that hold promise.
GlobeNewswirePAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSASAN DIEGO, June 10, 2024 (GLOBE NEWSWIRE) -- In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: RMD) presented 13 new clinical studies at SLEEP 2024, the annual joint meeting of the American Academy of Sleep Medicine and the Sleep Research Society. Held in H
